CHU de Montpellier Hopital Arnaud de Villeneuve; de Génétique

Montpellier 34295

0 studies enrolling now · 3 studies all time

What they study most

Down Syndrome, Idiopathic Pulmonary Fibrosis

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis — Stopped early
• A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) — Completed
• Non-drug Study to Evaluate the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down Syndrome — Completed